Johnson & Johnson reported third-quarter earnings with adjusted EPS of $2.42, surpassing expectations. Sales rose 5.2% to $22.47B. J&J updated its 2024 adjusted EPS guidance, lowering it slightly to ...
Johnson & Johnson is discontinuing its phase 2 field study on the efficacy of a candidate drug for dengue, according to a ...
Drug major Johnson & Johnson (JNJ), while reporting weak earnings but higher sales in its third quarter, on Tuesday trimmed its ...
At age 12, the Blue Jackets' future fifth overall pick was a scrawny forward who saw himself in a small, dynamic rookie for ...
Few things are as important for a team as having a solid and reliable shortstop and figuring out who that player will be for ...
MIT's Simon Johnson is one of this year's Nobel Memorial Prize in Economic Sciences. HIs work focuses on how institutions ...
The Dwayne Johnson-starring Christmas-themed comedy adventure film “Red One” is set for a theatrical release in mainland ...
6hOpinion
During an endorsement interview with The Kansas City Star Editorial Board, Vanessa Riebli, Democratic candidate for Johnson ...
At rallies, Johnson and former President Donald Trump have blamed Vice President Kamala Harris for the high cost of goods and ...
JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback